These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 13720155)
1. Problems of allocation and distribution of influenza vaccines. DAVIS DJ Am Rev Respir Dis; 1961 Feb; 83(2)Pt 2():168-70. PubMed ID: 13720155 [No Abstract] [Full Text] [Related]
2. Some problems in the standardization and control of influenza vaccine in 1957. MURRAY R Am Rev Respir Dis; 1961 Feb; 83(2)Pt 2():160-7. PubMed ID: 13727031 [No Abstract] [Full Text] [Related]
3. Inactivated influenza virus vaccines. Past, present, and future. DAVENPORT FM Am Rev Respir Dis; 1961 Feb; 83(2)Pt 2():146-56. PubMed ID: 13719955 [No Abstract] [Full Text] [Related]
4. [Vaccines against influenza]. PONTECORVO M; PICCIOTTO L; LA ROCCA V Riv Ist Sieroter Ital; 1955; 30(4):297-309. PubMed ID: 13281365 [No Abstract] [Full Text] [Related]
5. TESTING influenza vaccines. Public Health Rep (1896); 1957 Oct; 72(10):861-4. PubMed ID: 13465950 [No Abstract] [Full Text] [Related]
6. A controlled test of Asian influenza vaccine in a population of families. SELTSER R; SARTWELL PE; BELL JA Am J Hyg; 1962 Jan; 75():112-35. PubMed ID: 13910491 [No Abstract] [Full Text] [Related]
7. Influenza vaccine. SMADEL JE Public Health Rep (1896); 1958 Feb; 73(2):129-32. PubMed ID: 13505997 [No Abstract] [Full Text] [Related]
9. [Depot effect of influenza adsorbate vaccine]. HENNEBERG G; WENGEL E Arch Gesamte Virusforsch; 1953; 5(3):237-41. PubMed ID: 13139438 [No Abstract] [Full Text] [Related]
10. Serological responses and clinical reactions to influenza virus vaccines. HIMMELWEIT F Br Med J; 1960 Dec; 2(5214):1690-4. PubMed ID: 13714414 [No Abstract] [Full Text] [Related]
11. [Influenza vaccine cultivation]. GROSS WO Arch Gesamte Virusforsch; 1959; 8(5):632-5. PubMed ID: 13650534 [No Abstract] [Full Text] [Related]
12. Studies in egg white antigen content of influenza virus vaccines. CHAO IT; SIEGEL BB; GROLNICK M J Allergy; 1960; 31():543-9. PubMed ID: 13692367 [No Abstract] [Full Text] [Related]
13. The use of beta-propiolactone for the preparation of virus vaccines. I. Selection of reaction conditions. POLLEY JR; GUERIN MM Can J Microbiol; 1957 Oct; 3(6):863-70. PubMed ID: 13472511 [No Abstract] [Full Text] [Related]
14. Variables influencing the preparation of influenza vaccines with formaldehyde. POLLEY JR Can J Microbiol; 1959 Apr; 5(2):237-44. PubMed ID: 13638900 [No Abstract] [Full Text] [Related]
15. [Effect of liver virus concentrations in anti-influenza vaccine on its immunological activity]. DEICHMAN GI; GRIGOR'EVA AG; VENUSTOV NV Vopr Virusol; 1958; 3(6):357-62. PubMed ID: 13636153 [No Abstract] [Full Text] [Related]
17. [Preparation and use of anti-influenza vaccine]. LACORTE JG; MONTEIRO E; LOURES JC Hospital (Rio J); 1962 Aug; 62():371-8. PubMed ID: 14461422 [No Abstract] [Full Text] [Related]
18. The use of beta-propiolactone for the preparation of virus vaccines. II. Antigenicity. POLLEY JR; GUERIN MM Can J Microbiol; 1957 Oct; 3(6):871-7. PubMed ID: 13472512 [No Abstract] [Full Text] [Related]
19. [A study on living influenza vaccine]. OKUNO Y Sogo Igaku; 1962 Mar; 19():247-8. PubMed ID: 14481661 [No Abstract] [Full Text] [Related]
20. The response to influenza vaccines as determined by levels of complement-fixing antibody in the acute-phase sera of patients with respiratory disease. CULVER JO; LENNETTE EH; NAVARRE G; KEMPE CH J Immunol; 1960 Jan; 84():98-105. PubMed ID: 13813266 [No Abstract] [Full Text] [Related] [Next] [New Search]